Unless there's some way to estimate how much money we have to give to AI companies before they cure cancer, we should at least consider the possibility that the true sum is "more money than exists now and that will ever exist." We should also consider that whatever benefits to cancer research that AI might deliver could come with a higher price-tag than the promising cancer research we're dropping because we can't find far more modest sums.
15/